uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
A Multicenter, Randomized, Blinded, Phase 3 Study of Pasireotide LAR vs Octreotide LAR in Patients with Metastatic Neuroendocrine Tumors (NET) with Disease-Related Symptoms Inadequately Controlled by Somatostatin Analogs
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Sciences, Endocrine Tumor Biology.
Show others and affiliations
2014 (English)In: Pancreas, ISSN 0885-3177, E-ISSN 1536-4828, Vol. 43, no 3, 508-508 p.Article in journal, Meeting abstract (Other academic) Published
Place, publisher, year, edition, pages
2014. Vol. 43, no 3, 508-508 p.
National Category
Gastroenterology and Hepatology
URN: urn:nbn:se:uu:diva-228360ISI: 000333166800083OAI: oai:DiVA.org:uu-228360DiVA: diva2:734048
6th Annual Meeting of the North American NeuroEndocrine Tumor Society, October 4–5, 2013, Charleston, South Carolina
Available from: 2014-07-14 Created: 2014-07-11 Last updated: 2014-07-14Bibliographically approved

Open Access in DiVA

No full text

Search in DiVA

By author/editor
Eriksson, BarbroÖberg, Kjell
By organisation
Endocrine Tumor BiologyDepartment of Medical Sciences
In the same journal
Gastroenterology and Hepatology

Search outside of DiVA

GoogleGoogle Scholar

Total: 221 hits
ReferencesLink to record
Permanent link

Direct link